New Directions and Practice Impacting Recommendations in Multiple Sclerosis
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Fenebrutinib Hits Key Phase 3 Marks in Relapsing and Primary Progressive MS
2
FDA Clears Phase 2a Clinical Trial to Test JOTROL in Patients With Parkinson Disease
3
OnabotulinumtoxinA Fails to Meet Primary End Point in Phase 3 PRECLUDE Trial for Episodic Migraine
4
Doxecitine/Doxribitine Approval Redefines Care in Thymidine Kinase 2 Deficiency: Fabian Somers, PhD
5
